Логотип Артген
  • About
    • Company Strategy
    • Group Structure
    • Board of directors
    • Management
    • Career
    • Contacts
  • Development
    • Drugs
    • Medical devices
    • Medical services
  • Biotech valuation
  • Activity
    • Areas of activities
    • Research and development (R&D) stages
    • Ecosystem
    • Acceleration
    • Commercialization
  • Investor
    • Disclosure of information
  • News
En
RU CN
  • Главная
  • News
  • News

    News, press releases, events, publications

    All categories
    All categories News Press releases Press about us
    Portfolio
    Portfolio Genetico Gemabank Nextgen Biotechnology Developments Betuvax Histograft Genotarget Reprobank Vitacel
    • 01.04.2026
      Press releases
      Artgen Biotech Increases Profit by 14% in 2025
    • 26.03.2026
      Press releases
      Genetico’s Revenue Grows by 60% Over Two Years
    • 23.03.2026
      Press releases
      Gemabank’s Revenue Growth Exceeds 40% Over Four Years
    • 19.03.2026
      Press releases
      Genetico Patents Embryo Genetic Diagnostics Technologies
    • 18.03.2026
      Press releases
      Clinical Trials of Combination Gene Therapy Using Russian Gene Therapy Drug to Be Conducted in Honduras
    • 17.03.2026
      Press releases
      Artgen Seed Fund and Brainbox.vc Invest RUB 15 Million in «Dolgozhitel» Digital Elderly Care Ecosystem
    • 16.03.2026
      Press releases
      Gemabank Discloses Parameters of Potential Additional Share Placement
    1 2 3 4 … 26
    footer logotype
    Follow us
    • Telegram
    • VK
    • Interfax-CRCI
    Moscow, Gubkina street, 3, b.1
    • info@artgen.ru
    • +7 (495) 646-80-76
    ©2003-2026 Artgen biotech
      • About the Company
      • Company Strategy
      • Group Structure
      • Board of Directors
      • Management
      • Career
      • Contacts
      • Development Portfolio
      • Drugs
      • Medical Devices
      • Medical Services
      • Activity
      • Areas of activities
      • Research and development (R&D) stages
      • Ecosystem
      • Acceleration
      • Commercialization
      • Investors
      • Biotech Valuation
      • Disclosure of information
      • Contacts
    • About the Company
      • About
      • Company Strategy
      • Group Structure
      • Board of Directors
      • Management
      • Career
      • Contacts
    • Development Portfolio
      • Drugs
      • Medical Devices
      • Medical Services
    • Activity
      • Areas of activities
      • Research and development (R&D) stages
      • Ecosystem
      • Acceleration
      • Commercialization
    • Biotech Valuation
    • Investors
      • Disclosure of information